isoflavones

DIETARY_SUPPLEMENT5 trials

Sponsors

Alliance for Clinical Trials in Oncology, National Center for Complementary and Integrative Health (NCCIH), The University of Texas Medical Branch, Galveston, Chinese University of Hong Kong, Hull University Teaching Hospitals NHS Trust

Conditions

Breast CancerCardiovascular RiskDiabetesDietary InterventionHot FlashesHot FlushesMemory LossPostmenopause

Phase 2

Phytoestrogens and Memory Decline in Menopause

CompletedNCT00051402

National Center for Complementary and Integrative Health (NCCIH)Memory Loss, Postmenopause

Start: 2002-12-31End: 2007-08-31Target: 96Updated: 2007-10-26

Soy Protein Supplement In Treating Hot Flashes in Postmenopausal Women Receiving Tamoxifen for Breast Disease

CompletedNCT00031720

Alliance for Clinical Trials in OncologyBreast Cancer, Hot Flashes, Hot Flushes

Start: 2002-03-31End: 2013-11-30Updated: 2016-07-13

Soy Isoflavones and Breast Cancer Risk Reduction

CompletedNCT00204490

The University of Texas Medical Branch, GalvestonBreast Cancer

Start: 2004-04-30End: 2023-05-31Updated: 2024-05-16

Unknown Phase

The Effects of Soy Protein and Isoflavones on Glycemic Control, Insulin Sensitivity and Cardiovascular Risk Factors

CompletedNCT00856882

Chinese University of Hong KongCardiovascular Risk, Diabetes

Start: 2007-10-31Updated: 2009-03-06

Effects of Combining Cocoa and Soy in Type 2 Diabetes

CompletedNCT01754662

Hull University Teaching Hospitals NHS TrustDietary Intervention, Type 2 Diabetes

Start: 2011-10-31End: 2013-06-30Updated: 2019-07-15

Related Papers

Soy isoflavones decrease fibroglandular breast tissue measured by magnetic resonance imaging in premenopausal women: A 2-year randomized double-blind placebo controlled clinical trial.

2022-10-2611 citations

Soy isoflavones interact with calcium and contribute to blood pressure homeostasis in women: a randomized, double-blind, placebo controlled trial.

2019-09-186 citations

The Effects of Soy Protein and Cocoa With or Without Isoflavones on Glycemic Control in Type 2 Diabetes. A Double-Blind, Randomized, Placebo-Controlled Study

Frontiers in Endocrinology2019-05-0933 citations